VivaMed NMDA Solutions is developing rapastinel into an opioid use disorder treatment.

VivaMed NMDA Solutions is developing rapastinel into an opioid use disorder treatment.
Vimana, the first startup out of the Duke-nference collaboration, is developing a multimodal generative AI platform to accelerate the development of precision diagnostics and therapies for neurological disorders.
Torque Bio is developing circular mRNA expression systems for gene therapy.
Spoolyard is developing an interactive platform for creating, remixing, and sharing audiovisual experiences.
Piximune Therapeutics is developing a novel class of antibodies designed to upregulate the innate neuroprotective mechanisms within the human retina to treat a broad range of retinal degenerative conditions, including dry AMD.
Paxos Medical is a neuromodulation startup focused on bringing peace to the lives of patients with pelvic heath disorders.
Navi Co. is developing digital workflow technology for managing entrepreneurship cohort coaching.
Metabosensor is developing a device and approaches to integrate metabolic data from patients to enable better precision medicine.
Lux One Technology is developing cellular resolution endoscopic imaging systems for in-vivo use.
Lullabee is developing a smart crib mattress that teaches children to become better sleepers.